Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

miR-222 inhibits pathological cardiac hypertrophy and heart failure

Cardiovascular Research(2023)10.1093/cvr/cvad184Source: DataRank Database

miR-222 inhibits pathological cardiac hypertrophy and heart failure is a research paper published in Cardiovascular Research (2023). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 4.14)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Haobo Li ORCID,Margaret H. Hastings ORCID,Chunyang Xiao ORCID,Federico Damilano,Colin Platt

Live enrichment

PubMed:38084908 PMC:PMC10939454 OpenAlex:https://openalex.org/W4389627721

American Heart Association

Grant: 20CDA35310184

American Heart Association

Grant: 23MERIT1038415

National Institutes of Health

Grant: R21AG077040

National Institutes of Health

Grant: R01AG061034

National Institutes of Health

Grant: R35HL155318

National Institutes of Health

Grant: K08HL161405

National Institutes of Health

Grant: T32GM007226

National Institutes of Health

Grant: 5T32HL007374-37

NHLBI NIH HHS

Grant: 5T32 HL007374

NHLBI NIH HHS

Grant: T32 HL007374

Else-Kröner-Fresenius Stiftung

German Center for Cardiovascular Research

Medical Faculty of Heidelberg University Medical School

FWCI

4.14

Citation Percentile

1.0%

Influential Citations

Citation Trend

2024

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10939454/pdf/cvad184.pdf

publisherhttps://academic.oup.com/cardiovascres/advance-article-pdf/doi/10.1093/cvr/cvad184/54914830/cvad184.pdf

publisherhttps://academic.oup.com/cardiovascres/article-pdf/120/3/262/57222131/cvad184.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10939454

Fields of Study

MicroRNA in disease regulationCardiac Fibrosis and RemodelingCongenital heart defects researchMedicineBiologyMiceAnimalsMicroRNAsCardiomegalyHeart FailureHeartHeart DiseasesMyocytes, CardiacDisease Models, AnimalHomeodomain Proteins

MeSH Terms

AnimalsDisease Models, AnimalHeartHeart DiseasesCardiomegalyHeart FailureHomeodomain ProteinsMyocytes, CardiacMicroRNAsMice

Keywords

Pressure overloadHeart failureMuscle hypertrophyPathologicalInternal medicineCardiac function curveMedicineCardiologyEndocrinologyCardiac hypertrophyMicroRNAPathological HypertrophyTransverse Aortic Constriction (Tac)

Sustainable Development Goals

SDG 0: Good health and well-being

miR-222 inhibits pathological cardiac hypertrophy and heart failure

FAIR Checklist

Authors (12)

Funding (13 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)